AIM
ORGO icon

Aigen Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Aigen Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
+11,150
New +$27.2K 0.01% 513
2022
Q1 		– Sell
-11,485
Closed -$108K – 928
2021
Q4 		$108K Buy
+11,485
New +$122K 0.01% 991

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Aigen Investment Management's ORGO Position: Q2 2026 in Review

Aigen Investment Management opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 11,150 shares worth $27.1K. The stake represents 0.01% of the portfolio and ranks #513 among its holdings. This is a return to the name: Aigen Investment Management previously reported a position in ORGO as recently as Q4 2021.

Aigen Investment Management first reported a position in ORGO in Q4 2021 and has held it in 2 quarters since. The position peaked at $108K in Q4 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Aigen Investment Management held 11,150 shares of Organogenesis Holdings worth $27.1K as of Q2 2026.
  • Organogenesis Holdings was a new Aigen Investment Management position in Q2 2026.
  • Organogenesis Holdings made up 0.01% of Aigen Investment Management's portfolio in Q2 2026, its #513 holding.
  • Aigen Investment Management first reported a position in Organogenesis Holdings in Q4 2021 and has held it in 2 quarters since.
  • Aigen Investment Management's Organogenesis Holdings position peaked at $108K in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.